Sanofi to Cut US Price of Its Most-Prescribed Insulin by 78% ...Middle East

News by : (Medscape) -
Sanofi said on Thursday it will cut US list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly. Reuters Health Information

Hence then, the article about sanofi to cut us price of its most prescribed insulin by 78 was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi to Cut US Price of Its Most-Prescribed Insulin by 78% )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار